ketoconazole and n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide

ketoconazole has been researched along with n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doss, GA; Karanam, BV; Kumar, S; Lanza, TJ; Lin, LS; Raab, CE; Reddy, VB; Samuel, K; Stearns, RA; Yu, NX; Zhang, AS1

Other Studies

1 other study(ies) available for ketoconazole and n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide

ArticleYear
In vitro and in vivo metabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeys.
    Xenobiotica; the fate of foreign compounds in biological systems, 2010, Volume: 40, Issue:9

    Topics: Amides; Animals; Antibodies, Monoclonal; Body Fluids; Brain; Drug Inverse Agonism; Female; Haplorhini; Humans; Ketoconazole; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Microsomes, Liver; Pyridines; Radioactivity; Rats; Receptor, Cannabinoid, CB1

2010